Death of 'precious and special' young man was 'unavoidable' , inquest hears
Jack Robert Bannister, aged 26, was described by his family as a popular and social man who was adored by all who met him.
Jack, who worked as a customer services assistant in Sainsbury's, was born with Pierre Robin syndrome and spondyloepiphyseal dysplasia congenital (SEDC), the same bone growth condition as award-winning actor, Warwick Davis.
Jack Bannister was described as 'special and precious' by family and friends at his inquest. (Image: Gillian Bannister) By the age of 11, Jack had undergone around 30 various operations for his condition, including a tracheostomy and hernia repair. He used a wheelchair and had full life expectancy, with his condition was not thought to have a direct impact on his lifespan.
The inquest heard that Jack, who was from Leigh, was a keen gardener who enjoyed holidaying abroad with his family and friends, expressed a strong interest in property valuations and loved spending time with his beloved pet dog, Lottie.
Family, friends and close loved ones gathered at Bolton Coroners Court dressed in bright orange clothing, Jack's favourite colour.
The hearing heard that on the evening of 17th December 2024, Jack began to experience abdominal pains in his stomach.
Despite calling 111 for an ambulance, Jack's family noted that there were 'severe delays' of up to almost two hours in him getting seen to and so decided to drive him directly to Royal Bolton Hospital.
READ MORE:
Speaking at the hearing, Jack's mum Gillian Bannister said: 'At first, we thought Jack was suffering from constipation, although this wasn't something he'd had issues with before.
'We were told by the nurse on the phone that the hospital would be notified of his condition and would be expecting him, but when we got there this was not the case.
'But Jack's condition began to deteriorate even further once he arrived to Royal Bolton, he was screaming out in pain. He has a high pain threshold because of his SEDC, so we knew that if he was shouting like this it must have been excruciating.
'Anyone who would pass he would shout to them; he was desperate for help. He began to say that he was struggling to breathe. He wasn't seen by the first triage for around 45 minutes, we were just told to wait for someone to be available.
'After he was eventually seen to by the first triage, I asked if there was a bed that he could use to stretch out, as he had just been cramped up in his wheelchair. It was only after I suggested he stretch out on the floor that they were able to provide us with a bed for him.
Jack, who worked as a customer services assistant in Sainsbury's, was born with Pierre Robin syndrome and spondyloepiphyseal dysplasia congenital. (Image: Gillian Bannister) 'He went an hour and a half without any pain relief. There was around four and a half hours between him entering the hospital to him getting seen to by the surgical registrar for a review.'
The inquest heard that there were delays for getting in contact with the surgical registrar, with senior doctors unable to contact them via the hospital's switchboard.
Jack's condition continued to worsen, the inquest heard that he was left 'crawling on all fours' due to pain following a CT scan whilst waiting for a surgical review.
Gill added: 'When the residential surgeon finally came in, we heard her ask the clinical physician 'why she had been called out for this'.
'We heard doctors arguing behind the curtain between themselves about where Jack should be best placed, he received atrocious care that evening.'
Doctors administered Jack with ketamine as a form of pain relief.
Gillian said: 'He began spasming after the ketamine was administered, he had total fear in his eyes. I'll never forget that look he gave me, this was the last time that he was ever conscious.
'I believe that there were significant delays at Royal Bolton that contributed to Jack's passing. I just want to know if he looked like the average person would this have happened.
'There was a series of significant mistakes, concerns about Jack's breathing were lot listen to, we tried to flag that his skin was mottling and didn't get a response from staff. We felt like we were invisible, there was very little communication about what was happening.
'At one point we were asked to describe what his quality of life was like to the surgical registrar; I mean what kind of question is that?'
Although multiple members of staff attempted to insert a life-saving nasogastric tube into Jack's nose on several occasions, the inquest heard that attempts were unsuccessful.
A needle decompression was considered by staff but deemed too high-risk and likely to result in gastric perforation.
Despite resuscitation attempts by doctors, Jack died after suffering from a cardiac arrest at 6.38am on 18th December.
A post-mortem examination found that his lungs had partially collapsed, and his stomach was 'significantly dilated and full of air' at the time of his death.
Speaking at the inquest, Dr Emma Wheatley, who compiled the NHS report following Jack's death which described his death as 'unavoidable' due to the surrounding circumstances and that the 'outcome would be the same.'
She said: "The nasal gastric tube would have been the life-saving procedure. But this wouldn't go through, despite multiple attempts from senior people.
'Staff were unable to relieve pressure on his stomach, which pushed on the diaphragm and made it difficult for him to breathe. The team were unable to balance the pressure between his lungs and the stomach.
'His triage took about 90 minutes that night, I'm not saying it is acceptable by any means, but unfortunately that is the standard.
'There was a lot of stress between the teams that night, it is not a place for clinical teams to discuss plans in front of patients. Training is now in place to make sure people are being civil to one another and making sure there's no blame amongst staff members.
'The quality-of-life question was insensitive, as this is difficult to determine. We are going to run a communications workshop about that so staff know how to get the best information out of people sensitively.
'Because we couldn't treat the primary problem, it just added to more and more problems, which started with the inability to get the tube in.'
Gill added: 'Jack lived life to the fullest, he had so much to live for and managed to cram so much into his cruelly cut short life.
'Everyone knew him and loved him, over 400 people attended his funeral including the staff at Sainsburys. He was popular, everyone would always compliment him on his beaming smile.
'Jack was the type of person who wanted to help everyone, he sat with his best friend, Jade, for 24 hours whilst she gave birth to his god daughter, Ophelia.
'He loved cars, a good gossip and designer clothes. He was so highly thought of and respected by so many people. He was my son, my best friend.
'Jack's death was undignified, and we still don't understand the reason for these delays on that night. There was so much that we believe could have prevented this and we felt like the communication wasn't there.
'We just exist now, we don't live. I believe he was let down by everyone there that night. I believe that they just looked at him, scratched their heads and didn't know what to do.
'He was the same as everyone else, he worked in Sainsburys and was adored by his customers, he could drive and had so many friends and family who cared deeply for him.
'SEDC is not a life-limiting syndrome, I believe that they were well out of their comfort zone in treating someone of a different size and shape.
'He should still be here.'
A fundraiser for Jack's family has raised over £2,000 of its initial £500 target.
Concluding, Coroner Ceri Owen said: 'There was a failure to offer collation at the end of Jacks' life, I don't know why that was.
'I appreciate those in the medical field have competing demands, steps were taken to deliver care by staff of all seniorities.
'It is impossible to say whether sooner intervention would have had a different outcome. I did feel that some of his treatment was sub-optimal, but I'm not satisfied that the cause of death is neglect in this case.
'I agree with the post-mortem on the cause of death being metabolic acidosis, small bowel obstruction and spondyloepiphyseal dysplasia congenital.
'He was waiting from 90-100 minutes that night, with 95 other patients in A&E. There were delays in him getting a surgical review because of the descended stomach.
'The increasing intrabdominal pressure meant that he had difficulty breathing and unfortunately suffered a cardiac arrest which required advanced care support.
'Ultimately, I rule the cause of death to be natural causes. I offer my sincerest condolences to Jack's family and friends.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 days ago
- Associated Press
Society of Interventional Oncology Announces First Site Approved for Enrollment in TRIBUTE Trial
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated with Percutaneous Ablation and Palliative Radiation Therapy WASHINGTON, D.C. / ACCESS Newswire / August 18, 2025 / The Society of Interventional Oncology (SIO) proudly announces that the Washington University School of Medicine in St. Louis, MO, USA, has been the first site approved and activated for enrollment in the society's second clinical trial, TRIBUTE: A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated with Percutaneous Ablation and Palliative Radiation Therapy. The Washington University School of Medicine site study physicians are Jack Jennings, MD, PhD, FSIR, and Clifford Robinson, Trial Drs. Jennings and Robinson are two of four physicians leading the TRIBUTE Trial, including Sean Tutton, MD, FSIR, FCIRSE, and James Urbanic, MD, from the University of California, San Diego. 'We are excited and pleased to share that Washington University School of Medicine, St. Louis, is our first site activated and is ready for patient enrollment in the TRIBUTE Trial,' said Jennings. 'We look forward to announcing other sites in the U.S. as they are approved for enrollment.' The TRIBUTE study is collectively supported by the study's Exclusive Pioneer Trial Partner, Varian, a Siemens Healthineers Company, the study's Catalyst Trial Partner, Stryker, Inc., and the study's Advocate Trial Partner, Boston Scientific Corporation. This is the first prospective, multi-center study to evaluate real-world outcomes (e.g., pain, patient reported outcomes, skeletal related events, healthcare utilization, etc.) in adult patients treated with both percutaneous ablation and palliative radiation therapy (RT) for symptomatic, high-risk metastatic bone lesions. The study was collaboratively designed and developed with the partnership of radiation oncology, which SIO sees as a critical multidisciplinary partner to the success of the study. Upon completion, the study will enroll 120 subjects from across sites in the United States. Percutaneous ablation and RT have different mechanisms of alleviating pain and causing tumor death that may work synergistically. Radiation therapy is a widely accepted treatment for painful bone metastases and provides palliation of pain for patients. Percutaneous ablation, a minimally invasive therapy for painful metastatic bone disease, can be performed with thermal modalities (e.g., radiofrequency, microwave, cryoablation) and requires minimal recovery. About the Society of Interventional Oncology (SIO) SIO serves as the only membership-based organization dedicated to the emerging field of interventional oncology (IO), working to establish, nurture, and support IO as the fourth pillar of cancer therapy alongside medical, surgical, and radiation oncology worldwide. IO therapies, such as embolization and tumor ablation, combine the expertise of oncology and radiology and use imaging technology to diagnose and treat localized cancers in ways that are precisely targeted and minimally or non-invasive. For more information, please visit Contact InformationTaylor Marks Marketing Manager 6089313414 SOURCE: Society of Interventional Oncology press release
Yahoo
2 days ago
- Yahoo
'Our priority remain patients and staff' - hospital needs to £37M of savings
Bolton NHS Foundation needs to save a staggering £37 million to balance the books. Health bosses say they, like other trusts, are facing challenges - but their priority remains patients, staff and the community. The trust, which runs the Royal Bolton Hospital, reported a £2.4 million deficit in April, with board members told the figure was £900,000 worse than planned at a recent meeting. Schemes are being drawn up to make these savings, which include the roll-out of an electronic stock system and a Mutually Agreed Resignation Scheme (MARS). Agency spending exceeded NHS England targets, accounting for 2.2 per cent of pay costs compared to the national benchmark of 1.5 per cent. A presentation from the Finance and Investment Committee said PwC had been approached to assist with evaluating the Trust's financial position. READ MORE: Royal Bolton Hospital in line for multi-million cash boost Bolton NHS waiting lists fall by more than 7000 people Bolton NHS Foundation Trust struggling to plug £29m funding gap It was noted that Public Dividend Capital funding cash has provided a temporary benefit of £2.0m and some other cash has been received in advance. Speaking at the board meeting, Bolton NHS FT Non-Executive Director Sean Harriss said: 'The Trust's issues around performance and quality are moving in the right direction, but we do have some challenges. 'It is something we need to keep an eye on as a board going forward, as we get back to targets there are questions as to where quality and delivery are put under strain. 'I think a collective refection from the executive team would be useful for understanding what's happening, with triangulation between those areas.' Chief Finance Officer Annette Walker also presented the annual accounts for 2024/25 to the Audit and Risk Committee, which showed a year-end deficit of £8.9 million before adjustments. After impairments and other technical items, the operational deficit stood at £5.9 million. The Trust's year-end cash balance was reported at just over £10.6 million, with £16.7 million in capital expenditure. The board was also told that the Trust is engaging collectively with other organisations in the system before seeking any additional cash support. Annette Walker, Chief Finance Officer at Bolton NHS Foundation Trust said: 'Along with other Trusts across Greater Manchester, we are currently facing financial challenges. A great deal of work needs to take place to deliver significant savings over the next twelve months and beyond, including really challenging ourselves on the choices we make and how our services operate. 'We have identified £37 million worth of cost improvement schemes, which is the amount we need to save, but know due to slippage and other pressures we are likely to experience, we need to aim to deliver even more to maintain a balanced budget. 'This will not be easy but we have structures in place to help us manage and stay on track with our financial recovery, and our priority will always be to do what's right for our patients, communities and staff.'
Medscape
06-08-2025
- Medscape
New GAC Guidance Leads Some to Ask: What Do We Do Now?
Clinicians and hospitals are struggling to navigate care for young patients with gender dysphoria following new federal guidance released earlier this year that favors psychotherapy and attempts to block recommended medical and surgical gender-affirming care (GAC) treatments. The Trump administration escalated efforts to bar GAC earlier this month when the Department of Justice (DOJ) issued more than 20 subpoenas to clinics and providers that offer the treatments to pediatric patients. The subpoenas came on the heels of a day-long workshop by the Federal Trade Commission, which is claiming the medical treatments may constitute unfair or deceptive trade practices. 'There has been steady ongoing pressure from this administration, trying to force providers to abandon standard of care treatments for adolescent gender dysphoria,' said Jack Turban, MD, a San Francisco pediatric psychiatrist and author of the book, Free to Be: Understanding Kids & Gender Identity told Medscape Medical News. 'Every major medical organization opposes these efforts. Nonetheless, the efforts have been successful in scaring physicians and pushing some hospitals to close their clinics and abandon their patients.' In the wake of directives against GAC, some hospitals are shuttering clinics that provided transgender care, physicians are being forced to provide information about their GAC practices, and patients and families are faced with confusion and concern about what to do next. At the same time, clinicians who provide GAC are facing threats from the public and confronting contrasting legal obligations about best treatment practices. Adding to the confusion, 16 states filed a lawsuit this week against the Trump administration, arguing that its actions amount to an illegal nationwide ban of GAC in minors. This rapidly changing and uncertain landscape has left many to ask: What do we do now? Escalation in Efforts: A Timeline The move to curb GAC treatment in pediatric patients began in January with an executive order signed by President Donald Trump that prohibits physicians from providing GAC to youth and threatens to withhold federal funding from hospitals that offer such care. Specifically, the order denounces the use of 'chemical and surgical mutilation,' which it defines as the use of puberty blockers, sex hormones, and any surgical procedure that attempts to alter or remove an individual's sexual organs to minimize or 'destroy their natural biological functions.' Family, medical providers, and organizations that serve transgender patients sued over the order and a federal judge issued a nationwide preliminary injunction blocking its enforcement. The Trump administration appealed the injunction, which is pending before the Fourth Circuit. The injunction is still in-effect, although plaintiffs claim the administration is violating the judge's injunction by sending notices to providers and continuing to make threats over the use of GAC. In April, US Attorney General Pam Bondi instructed US attorneys to investigate and prosecute health centers for treating adolescents with GAC, suggesting that providing certain types of treatment may run afoul of several federal laws. A report on the use of GAC to treat gender dysphoria in pediatric patients issued in May by the Department of Health and Human Services (HHS) departed from accepted guidelines from most physician associations, suggesting that psychotherapeutic approaches are optimal. The Trump administration later sent letters threatening action if providers fail to follow the HHS guidance. A number of hospitals across the US received a letter in May from the Centers for Medicare and Medicaid Services, requesting information about their GAC practices, including billing information, provider financials, and information on informed consent practices for pediatric patients. The latest escalation came on July 9 when the US DOJ sent more than 20 subpoenas to doctors and clinics involved in performing transgender medical procedures on children. The department's investigations include healthcare fraud, false statements, and other allegations, according to a DOJ statement. Also in July, the Federal Trade Commission (FTC) held a workshop on the 'unfair or deceptive trade practices' of GAC. During the workshop, FTC officials said it would be a new priority for the agency to use its authority to combat 'unfair or deceptive practices related' to GAC. FTC Commissioner Melissa Holyoak stated it's the FTC's role to 'protect children from deceptive statements regarding such treatments' and that the agency has a strong history of enforcement actions against unfair and deceptive healthcare-related claims. In August, 16 states and the District of Columbia filed a federal lawsuit against the administration, arguing its actions against clinicians and medical facilities amount to a nationwide ban on GAC for people younger than 19 years. Such actions are illegal, the states argue, because there is no federal law banning GAC in minors. Caught in the Middle The federal directives and subsequent lawsuits have led to an increase in queries from confused and worried patients and parents, said a Tennessee pediatrician and member of the Tennessee Chapter of the American Academy of Pediatrics (AAP) who asked to remain anonymous due to concerns about his personal safety. In Tennessee, physicians have been restricted from prescribing hormone therapy or puberty blockers to patients younger than 18 years for the purpose of treating gender dysphoria since the state's 2023 ban. In June 2025, the US Supreme Court upheld the Tennessee ban, effectively clearing the way for other states to restrict or ban GAC. To date, more than 25 have enacted bans or policies that limit youth access to the treatments. Since Tennessee's ban, physicians have been referring young patients seeking treatment with puberty blockers or hormone therapy to other states for care, the Tennessee pediatrician said. Some outside clinics have now closed or are turning away patients. In some cases, the patients have been started on hormone replacement at the out-of-state clinics, he said. 'They're left up in the air and [wondering], 'Well, what do we do now?'' he said. 'There's not anything that we can do to directly help them.' As providers attempt to navigate an increasingly politicized medical landscape, they find themselves caught in the middle between patients seeking treatment and an acute awareness that how they respond could harm their entire health systems, Meredithe McNamara, MD, a pediatrician and assistant professor at Yale School of Medicine and co-director of the Integrity Project at the Yale Law School, New Haven, Connecticut, told Medscape Medical News . McNamara practices GAC, primarily for patients 18 years or older. 'If an institution shuts down their gender services in anticipation of brutal political backlash, they're going to see an uptick in mental health emergencies in their psych units and their ICUs,' McNamara said. Whether the administration will take action against clinicians and hospitals that continue to follow GAC guidance from the American Medical Association (AMA) and the AAP is unclear, McNamara said. 'I don't think anybody knows right now,' McNamara said. 'All of these threats, it's saber-rattling, it's rhetoric.' Wave of Clinic Closures Based on the recent closure of clinics and the halting of GAC-related treatment at some hospitals, the pressure from the Trump administration appears to be working, Jack Drescher, MD, a psychiatrist and psychoanalyst in private practice in New York City and a past president of the New York County Psychiatric Society, told Medscape Medical News . Earlier this year, Denver Health in Colorado stopped providing gender-affirming surgeries for those younger than 19 years and Children's National Hospital in Washington, DC, paused prescriptions of puberty blockers and hormone therapy. Hospitals in Illinois, Virginia, New York, and a number of other states have followed suit, even in cases where state laws allow GAC treatments in minors. In June, Stanford Medicine became the latest center to pause certain GAC services for patients younger than 19 years. Stanford Medicine said in a statement that it paused the surgeries after careful review of the latest actions and directives from the Trump administration and consultation with clinic leadership. 'We took this step to protect both our providers and patients,' Stanford Medicine said in the statement. 'This was not a decision we made lightly, especially knowing how deeply this impacts the individuals and families who depend on our essential care and support. Even as circumstances change, we remain committed to providing high quality, thorough and compassionate medical services for every member of our community.' One of the nation's oldest and largest trans youth centers, the Center for Transyouth Health and Development at Children's Hospital Los Angeles in Los Angeles closed its doors in July. The center's Medical Director, Johanna Olson-Kennedy, MD, declined a request to speak about the closure. In a statement, the center acknowledged the upcoming closure and said the staff was 'heartbroken to learn of the decision from hospital leaders, who emphasized that it was not made lightly but followed a thorough legal and financial assessment of the increasingly severe impacts of recent administrative actions and proposed policies.' 'Not Based on Science' Many families have left states with GAC-related bans because their children can no longer get care, Drescher said, adding that in some areas, parents are being accused of abusing their children for providing them with GAC. 'We're seeing something similar to what happened with attitudes toward abortion, which is that there are parts of the country where you can no longer access care,' Drescher said. The landscape is also becoming more worrisome for physicians who provide GAC, he added. In another parallel to threats made against clinicians who perform abortions, the names of hospitals and providers who provide GAC have been shared publicly on social media online. Drescher referenced one specific website that hosts such a list and provides data on the top providers that have billed for gender-related surgical procedures for minors. The names of physicians who practice GAC are included in some of the content, according to a review by Medscape Medical News. Medical Groups Respond Medical associations widely condemned the HHS report and other actions by the Trump administration to clamp down on GAC. The AAP questioned the credibility of the report, saying the report 'misrepresents the current medical consensus and fails to reflect the realities of pediatric care.' Similarly, a joint statement from the American Psychiatric Association and other leading medical associations said physicians should not be criminalized or penalized for 'providing care and that medical standards of care and physician training and education must remain evidence-based and free from political interference.' The AMA and other associations have long recommended a staged process for transgender minors that allow youth to explore and live the gender they identify with, while keeping other options open. According to the AMA, evidence has consistently shown that providing GAC that is age-appropriate and evidence-based, leads to improved mental health outcomes. Denying such care on the other hand, has been linked to a higher incidence of anxiety, depression, and self-harm in young people, the AMA stated. 'Gender-affirming care seeks to minimize the distress trans individuals experience by providing a supportive, nonjudgmental environment that acknowledges the individual's gender identity, or uncertainty about their gender identity,' former AMA President Jack Resneck Jr, wrote in a recent AMA article. 'This type of care also offers interventions to reduce the incongruence between gender identity and the individual's sex assigned at birth and gives patients who struggle with their gender identity the time and support they need to resolve that struggle,' he added. Legal, Ethical Questions Raised However, an executive order cannot change state law or federal regulations, said Craig Konnoth, a professor at the University of Virginia School of Law, Charlottesville, Virginia. Konnoth wrote in a June article about the legal and ethical impacts of the administration's executive order in Health Affairs . 'It basically has no force,' Konnoth told Medscape Medical News . 'It says to agencies, 'please change the law,' but does not change the law itself. The executive order isn't a good reason for organizations to stop providing care, and in fact, in many jurisdictions, organizations are required under the law to keep providing care.' In his Health Affairs piece, Konnoth called the criminal actions threatened by the administration, such as violating female genital mutilation protections and running afoul of the Food, Drug, and Cosmetic Act, 'far-fetched.' He noted that pediatric procedures rarely involve genital surgery, and that state protections already prohibit fraud and misrepresentation in medical care. Even the funding withdrawal warnings lack immediate legal effect, he said. To change the conditions of a hospital's participation in Medicare and Medicaid would mean a rulemaking process that would likely take more than a year. The flip side is that hospitals and physicians could land in legal or ethical trouble for ending GAC, according to Konnoth. A number of states prohibit discrimination based on gender identity. In addition, state laws generally prohibit abrupt cessation of care, he said. Patients can sue physicians over a sudden withdrawal of care without sufficient notice and time to find alternative treatment. 'Physicians, I will fully admit, are caught in a difficult spot because you've got conflicting threats you are facing,' he said. 'But the fact remains that the law in many jurisdictions requires physicians to keep providing care.' McNamara said the differing laws and obligations make practicing medicine extremely challenging for physicians right now. 'You don't provide care, or you do provide care, and the negative consequences are devastating on either side,' she said. 'What we're dealing with is the question of: What force is the most influential and powerful right now? These are things the medical profession was never supposed to deal with.'
